Over 6,000 Manufacturers, 53,000 Plus Retail & Wholesale Licensees Avail Gujarat FDCA-MDMLA Mobile App: Dr Koshia

Mumbai: As of today, over 6,000 manufacturers and 53,000 plus retail and wholesale licensees are availing Gujarat FDCA-mDMLA mobile app as part of ushering in good governance practices in the state, informed Gujarat FDCA commissioner Dr H G Koshia.

A mobile application for all the stakeholders including the manufacturers and retailers is aimed at bringing in accountability, transparency, inclusivity, uniformity and timeliness without disrupting the existing systems and protocols.

Gujarat FDCA’s transition from its e-governance model to m-governance model will help all the licensees under one single platform to facilitate easy access to regulatory information, licensing rules, procedures, protocols and processes.

Earlier, all operations were done offline for which the applicant had to come in person to apply in the office, follow up the application and get the license. To do all the above operations online, the officials of Gujarat FDCA and National Informatics Centre (NIC), Government of India (GoI) then created a web portal cosmla.gujarat.gov.in to ease the issuance of licenses with transparency and stringent regulatory oversight. The m-governance app has successfully merged all the online platforms at one place for faster, real time access towards getting status of the application in a seamless manner.

The mobile app is also aimed at helping ayurvedic medicine and cosmetic manufacturers and sellers also through this e-governance initiative.

Gujarat became the first state in the country to issue online licenses to allopathic medicines through the newly launched FDCA-mDMLA mobile app. The mobile application was launched on Good Governance Day on December 25, 2023 by the Gujarat Chief Minister Bhupendra Patel.

The m-governance system will have an oversight from a senior FDA official of the Assistant Commissioner rank.

Dr HG Koshia further informed that FDCA Gujarat is the first in the country to develop a mobile app to better deliver these services to stakeholders. The direct benefit of this mobile app is that under ease of doing business (EODB), manufacturers and drug sellers of the state will be able to access their related operations, services and information through mobile anywhere at any time.

Dr Koshia further explained that the mobile app has been prepared for total 24 types of categories with main license related functions of online platforms like online Extended Licensing Node (XLN), drug manufacturing license application (DMLA), iDMLA, COSMLA, AYUMLA and CERTIFICATE through this mobile app.

“All types of digitally signed licences, certificates, approvals etc. provided by the system can be obtained through mobile and the applicant can know the status of the application made by him on the mobile. Moreover, all the services of the Right of Citizens to Public Service (RCPS) Act are also covered in the app,” Dr Koshia added.

Related Posts

  • Pharma
  • July 27, 2024
  • 34 views
Mankind Pharma Acquires Bharat Serums And Vaccines For Rs 13,600 Crore

Mumbai: Mankind Pharma on Thursday said it has entered into a definitive agreement to acquire a 100 per cent stake in Bharat Serums and Vaccines (BSV) from private equity firm Advent International for…

  • Pharma
  • July 27, 2024
  • 45 views
Australian Mayne Pharma Sues Sun Pharma Over Patent Infringement

Canberra: Mayne Pharma has filed a lawsuit against Sun Pharma over infringements of patents related to a certain product used for menopause-related vaginal pain, the Australian drugmaker said on Thursday.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Mankind Pharma Acquires Bharat Serums And Vaccines For Rs 13,600 Crore

Mankind Pharma Acquires Bharat Serums And Vaccines For Rs 13,600 Crore

Australian Mayne Pharma Sues Sun Pharma Over Patent Infringement

Australian Mayne Pharma Sues Sun Pharma Over Patent Infringement

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards